These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9850919)

  • 1. What are the relations between Lewy body disease and AD?
    McKeith IG; Ince P; Jaros EB; Fairbairn A; Ballard C; Grace J; Morris CM; Perry RH
    J Neural Transm Suppl; 1998; 54():107-16. PubMed ID: 9850919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.
    Jacobson SA; Morshed T; Dugger BN; Beach TG; Hentz JG; Adler CH; Shill HA; Sabbagh MN; Belden CM; Sue LI; Caviness JN; Hu C;
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1009-14. PubMed ID: 25027359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
    Dai DL; Tropea TF; Robinson JL; Suh E; Hurtig H; Weintraub D; Van Deerlin V; Lee EB; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol; 2020 Oct; 140(4):449-461. PubMed ID: 32749525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
    Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM
    Dementia; 1994; 5(5):215-28. PubMed ID: 7951676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.
    Lippa CF; Smith TW; Swearer JM
    Ann Neurol; 1994 Jan; 35(1):81-8. PubMed ID: 8285597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
    Ballard CG; Jacoby R; Del Ser T; Khan MN; Munoz DG; Holmes C; Nagy Z; Perry EK; Joachim C; Jaros E; O'Brien JT; Perry RH; McKeith IG
    Am J Psychiatry; 2004 May; 161(5):843-9. PubMed ID: 15121649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.
    Gearing M; Lynn M; Mirra SS
    Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa.
    Hansen LA; Masliah E; Galasko D; Terry RD
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):648-54. PubMed ID: 8229084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
    Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
    Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy body pathology in Alzheimer's disease.
    Kotzbauer PT; Trojanowsk JQ; Lee VM
    J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.
    Merdes AR; Hansen LA; Jeste DV; Galasko D; Hofstetter CR; Ho GJ; Thal LJ; Corey-Bloom J
    Neurology; 2003 May; 60(10):1586-90. PubMed ID: 12771246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropathologic Aspects of Co-occurrence of Dementia with Lewy Bodies and Alzheimer's Disease].
    Takao M
    Brain Nerve; 2018 Aug; 70(8):905-913. PubMed ID: 30082500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
    Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
    Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.